QuantRx Biomedical Corp. (QTXB.OB) Forms Joint Venture with NuRx Pharmaceuticals to Capitalize on Point-of-Care Products
QuantRx Biomedical Corp. is a diagnostics company engaged in the development and commercialization of innovative diagnostic products centered on its patented technology platforms. Friday, the company announced its joint venture with NuRx Pharmaceuticals Inc. (NUXP.OB), a life sciences company engaged in the research and development of oncology products and relative care. The joint venture was formed to accelerate efforts to take advantage of Point-of-Care (POC) products. Per the agreement, NuRx will provide the new venture, QN Diagnostics LLC, with more than $5 million of working capital, which will be used for marketing and revenue generation of its POC line of…